News & EventsSee All
Brain Awareness Week (BAW) 2019 is being celebrated March 11th-17th. This year, FHC has become a BAW partner, joining other organizations in a global partnership committed to educating the public about the brain and the promise of brain research.
Australia’s 9News recently featured a story about a new surgical approach, using FHC products, that is treating Australian patients affected by Parkinson’s disease.
BOWDOIN, ME – January 8, 2019 – FHC, Inc., announced today that is has received 510(k) clearance from the Food and Drug Administration (FDA) for the Guideline 4000 5.0™ electrophysiological recording and stimulation system.